Because informed decisions lead to better outcomes
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society.
We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity at scale to ensure value to our customers. We bring that same rigor to our analytical solutions for researchers, health professionals, institutions and funders.
Trusted for 140 years
We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users spend more time making breakthroughs and drive societal progress.
Since the year 2000, more than 99% of the Nobel Laureates in science have published in Elsevier journals.
Researchers and healthcare professionals rely on our 2,650 digitized journals, including iconic publications such as The Lancet founded in 1823 and Cell one of the flagship titles from Cell Press; our 42,000+ eBook titles; and our iconic reference works, such as Gray's Anatomy.
560k+ peer-reviewed articles
Elsevier serves the global research community, publishing over 560,000 peer-reviewed articles in 2020 — 90% more than a decade ago.
94% of the top 100 health systems
Most of the top 100 health systems (ranked by bed count) use at least one of Elsevier’s Clinical Solutions.
The future is open, and we are here to support you.
We believe in open science and open access to knowledge. We’ve created a wide-ranging portfolio of open access publishing options for authors and researchers across all subject areas. Nearly all our journals already offer immediate open access options, and we are committed to finding a sustainable path so we can extend this to all our titles.
Every day, research and health professionals dedicate themselves to improving outcomes for communities, patients and society at large. Elsevier is committed to quality and innovation to improve the value we deliver to researchers, research leaders, librarians, funders, healthcare professionals and educators in an open, inclusive and collaborative manner.
We support academic researchers as they seek to break ground with their discoveries. We are honored to convene and support expert editorial teams who, in turn, ensure the quality of research. We enhance and amplify the work of researchers and help them stay on top of the never-ending flow of information in their fields and related fields. And we provide insights that help find funding, identify international, interdisciplinary and commercial collaborators, and manage data to ensure that their work is reproducible.
We support librarians in their role as connectors of the quality of knowledge and knowledge dissemination to advance their institutional mission. We provide options to publish and showcase their collections and share them openly.
Leaders & funders
We help research leaders and funders understand their performance and the research landscape, identify researchers and cross-sector partners to advance their programs, recognize funding opportunities and manage the research enterprise.
We help physicians, nurses and other clinicians improve the lives of patients. We provide evidence-based tools to help healthcare providers make faster, better decisions at the point of care and improve outcomes for patients. We provide content and digital tools to help them manage their work more efficiently and give patients a consistent quality of care.
Health educators and students
We work with health educators to prepare today's students for successful careers in medicine, nursing and health professions, providing world-class content and innovative teaching and learning tools that improve educational outcomes and help prepare students for healthcare practice.
We support corporate R&D professionals with information, data and analytics that allow them to save time, make better decisions and innovate at the speed and scale society expects of them.
Elsevier has really positioned itself as a data science company, and with an enormous amount of data science and analytic expertise, what type of things can we work on together?
Elsevier is applying advanced Machine Learning and Natural Language Programming techniques to help researchers, engineers and clinicians perform their work better.
Elsevier creates tools that put users in control, helping them work faster, manage complexity and free up time to focus on their goals and improve outcomes in the areas of R&D Solutions, Clinical Solutions, Research Platforms, Research Intelligence and Education.
ScienceDirect®, the world’s largest platform dedicated to peer-reviewed primary scientific and medical research, hosts more than 18 million pieces of content from over 4,300 journals and over 42,000 eBooks and receives more than 18 million visitors a month. Elsevier has continued to invest in ScienceDirect and integrate new remote access methods to provide researchers with the ability to easily use its tools when working from home, safe in the knowledge that they are doing so securely, and that their privacy and data are protected.
Scopus® uniquely combines a comprehensive, curated abstract and citation database with enriched data and linked scholarly content; with over 81 million records across 25,000 journals, sourced from more than 5,000 publishers. Scopus enables researchers to track, analyze and visualize the world’s research output.
SciVal® provides insights into the research performance of over 19,000 research institutions. This decision tool helps academic and government research administrators and leaders to establish, execute and evaluate research strategies by leveraging bibliometric data from Scopus and other data types such as patent citations and usage data.
Reaxys® is a chemistry research and education database with chemical substance, properties, reaction and medicinal chemistry data for both bench chemists and data scientists supporting drug discovery and chemical R&D. It's used in the pharmaceutical and chemical industries and in the academic & government sectors. In 2020, Reaxys increased its content with 1.8 million key substances in 6.4 million documents from 16,000 journal titles and 12 patent offices. In addition, Elsevier developed an award-wining Predictive Retrosynthesis module leveraging cutting-edge AI and machine learning technologies to help researchers accelerate synthetic chemistry workflows in drug discovery.
Complete Anatomy is the world’s most advanced 3D anatomy education platform, featuring ground-breaking technology and content and unique collaboration and learning tools. In 2020, Complete Anatomy surpassed 1.9 million registered users. It's used in more than 300 medical schools and universities worldwide.
Elsevier’s flagship clinical reference platform, ClinicalKey®, gives physicians, nurses and pharmacists access to leading Elsevier and third-party reference and evidence-based medical content, including over 550 clinical overviews, which provide quick answers and summaries, and more than 4.8 million images and 66,000 medical and surgical videos in a single, fully integrated site. ClinicalKey is accessed in over 90 countries and territories and by over 1,900 institutions in North America alone. ClinicalKey Student is used by more than 100,000 students in over 170 medical schools and 130 nursing schools.
Knovel® is a decision support tool for engineers that helps them select the right materials – a mission-critical use case in product development across chemicals, oil & gas and other engineering-focused industries.
An innovative research management and social collaboration platform, Mendeley® helps more than 15 million users worldwide, from undergraduates to professionals, organize, write and collaborate. Mendeley Data enables researchers to make their research data publicly available by providing an open research data repository.
ClinicalPath® (formerly Via Oncology) provides clinical pathways delivering personalized, evidence-based oncology guidance at the point of care. Elsevier’s analytics capabilities in oncology help our ClinicalPath customers answer increasingly complex questions about the delivery of cancer care, such as appropriate use of precision oncology and treatment adherence. ClinicalPath’s network in North America serves more than 2,000 cancer physicians, 52 practices in 32 states, 15 academic medical centers, 27 hospital systems and 10 community practices. ClinicalPath won the 2020 MedTech Breakthrough Award for Best Computerized Decision Support Solution for the second consecutive year.
Sherpath®, an adaptive teaching and learning solution for nursing and health education, provides highly focused, personalized and adaptive learning paths at over 400 institutions, supporting more than 50,000 enrollments.
SSRN® is an open access online preprint community where researchers post early-stage research prior to publication in academic journals. Devoted to the rapid worldwide dissemination of research, it hosts specialized research networks in the social, life and physical sciences. SSRN currently has over 2.6 million monthly visitors and over 950,000 paper abstracts from more than 500,000 authors. It has extracted 22.9 million references and matched over 2.7 million citations from its full-text database of early stage research.
Partnering for a better world
Although much progress has been made, our world still faces grand challenges: tackling climate change; ensuring food and water security; helping more people live longer, healthier lives; reducing social inequality while also driving economic growth. It is our goal to help accelerate the progress of researchers and health professionals through innovation in partnership with the communities we serve – and to play our part in building a better future for research, health and people everywhere.
Kumsal Bayazit, CEO of Elsevier is co-chair of the Inclusion & Diversity Advisory Board.
I&D are critical for science, innovation and society. We are committed to driving diversity on all fronts – gender, race, age, nationality, sexual orientation and ability. Progress for one will lift all, creating a more inclusive mindset and helping to address systemic issues.
To support the extraordinary efforts of the health and research communities combatting coronavirus, Elsevier opened a range of free resources beginning in late January 2020.
Since 2016, Amref Health Africa and the Elsevier Foundation have partnered to implement mobile learning solutions for professional nursing development across East Africa.
With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is where you are to support you
Elsevier employs 8,600 people including 1,906 technologists around the world. Many of us began our careers in research and healthcare. We share the community's belief in the power of science, research and medicine.
Have a question about our solutions?
We are a business with a unique perspective: At the intersection between analysis and content; in the place where information becomes knowledge; at the point where research, healthcare, and technology come together. Discover Elsevier.
Interested in working at Elsevier?